Wielisa Anti-Gbm Test System

FDA 510(k) K974169 · Wieslab AB

Substantially Equivalent

510(k) numberK974169

Submission

Device name
Wielisa Anti-Gbm Test System
Applicant
Wieslab AB
Frederick, MD, US
Received
November 5, 1997
Decision date
February 17, 1998
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DBL – Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5660
Specialty
Immunology

Other 510(k)s with product code DBL

510(k)DeviceApplicantDecision
K180202Histofluor Rodent LKS Fluorescent Antibody Test System, Image Navigator by Immuno ConceptsDBL · Traditional Immuno Concepts, N.A. , Ltd.10/19/2018SE
K980312Nova Lite EndomysialDBL · Traditional Inova Diagnostics, Inc.04/02/1998SE
K971464Immunoscan Anti-Gbm Quantitative KitDBL · Traditional Euro-Diagnostica AB10/29/1997SE
K971658Mouse Liver Kidney Stomach Diagnostic Test KitDBL · Traditional Jay H. Geller05/23/1997SE
K963525Diastat Anti-Glomerular Basement Membrane KitDBL · Traditional Shield Diagnostics, Ltd.11/07/1996SE
K955431Rit Liver, Kidney, Stomach Ifa KitDBL · Traditional The Binding Site, Ltd.04/23/1996SE
K953495Eia Kit for the Detection of GBM AntibodiesDBL · Traditional Scimedx Corp.04/10/1996SE
K944192Anti-Nuclear Antibody (Ana) Test Kit W/Rat LiverDBL · Traditional Light Diagnostics03/06/1995SE
K944191Anti-Nuclear Antibody(Ana) Test Kit W/Mouse LiverDBL · Traditional Light Diagnostics03/06/1995SE
K913360Anti-Reticulin Antibody (Ara) TestDBL · Traditional Immco Diagnostics, Inc.09/26/1994SE

More from Immco Diagnostics, Inc.

510(k)DeviceDecision
K981750Wielisa Anti-Gbm, Anca Screening Kit Test SystemMOB · Traditional 07/22/1998SE
K981748Wielisa Anca Screening Kit Test SystemMOB · Traditional 07/22/1998SE
K974167Wielisa PR-3 Anca Test SystemMOB · Traditional 02/17/1998SE
K974166Wielisa Mpo Anca Test SystemMOB · Traditional 02/17/1998SE

Questions and answers

When was Wielisa Anti-Gbm Test System cleared by the FDA?

Wielisa Anti-Gbm Test System (K974169) received a 510(k) decision of Substantially Equivalent on February 17, 1998, 104 days after the submission was received.

What is the product code of K974169?

The FDA product code is DBL – Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control, a Class II (moderate risk) device regulated under 21 CFR 866.5660.